Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Foscarnet Induction vs Maintenance for CMV GI Disease
NCT00002145Phase 3Completed
- Sponsor
- Astra Merck
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of foscarnet sodium in Cytomegalovirus gastrointestinal disease, sponsored by Astra Merck. Status: completed.
02
Drugs
foscarnet sodium
03
Conditions
Cytomegalovirus gastrointestinal disease
Beyond the preview
Go deeper on NCT00002145.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002145.